Literature DB >> 15858691

Rapid diagnosis of Helicobacter pylori infection in dyspeptic patients using salivary secretion: a non-invasive approach.

S K Tiwari1, A A Khan, K S Ahmed, I Ahmed, F Kauser, M A Hussain, S M Ali, A Alvi, A Habeeb, Z Abid, N Ahmed, C M Habibullah.   

Abstract

INTRODUCTION: Current guidelines that recommend Helicobacter pylori eradication treatment without endoscopy in selected patients underscore the importance of non-invasive testing. The accuracy of saliva as a non-invasive specimen was compared with that of invasive tests in pretreatment diagnosis of H. pylori infection.
METHODS: One hundred patients undergoing gastroscopy were grouped into 80 symptomatic and 20 asymptomatic subjects and were investigated for the presence of H. pylori in saliva and stomach. Samples tested comprised saliva and gastric biopsies collected from each patient. Exclusion criteria were history of peptic ulcer, bleeding ulcer, cancer or recent use of antibiotics, proton pump inhibitors and non-steroidal anti-inflammatory drugs. Two sets of primers homologous to 534 bp fragment of H. pylori DNA, which have been shown previously to be highly specific and sensitive, were used for the polymerase chain reaction (PCR) amplification.
RESULTS: 72 (90 percent) of the symptomatic group and 10 asymptomatic subjects were infected with H. pylori in the stomach as determined by histology and direct PCR amplification of biopsy DNA obtained from each subject. H. pylori DNA was identified in the saliva of 70 (87.5 percent) symptomatic subjects and 12 (60 percent) asymptomatic control subjects.
CONCLUSION: High rates of detection using saliva as a specimen indicate that saliva of the infected person could serve as a reliable non-invasive alternative to detect the presence of H. pylori infection in comparison to the currently available standard diagnostic tests.

Entities:  

Mesh:

Year:  2005        PMID: 15858691

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  7 in total

1.  Preliminary examination of herbal extracts on the inhibition of Helicobacter pylori.

Authors:  Gulcihan Guzeldag; Lutfiye Kadioglu; Aysun Mercimek; Fatih Matyar
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

2.  Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats.

Authors:  Kiran S Raygude; Amit D Kandhare; Pinaki Ghosh; Arvindkumar E Ghule; Subhash L Bodhankar
Journal:  Inflammopharmacology       Date:  2012-02-14       Impact factor: 4.473

3.  Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases.

Authors:  Santosh K Tiwari; Aleem A Khan; Mohd Ibrahim; Mohd Aejaz Habeeb; C M Habibullah
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

4.  Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study.

Authors:  Bikha Ram Devrajani; Syed Zulfiquar Ali Shah; Aftab Ahmed Soomro; Tarachand Devrajani
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

5.  Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples.

Authors:  Mitsushige Sugimoto; Jeng-Yih Wu; Suhaib Abudayyeh; Jill Hoffman; Hajer Brahem; Khaldun Al-Khatib; Yoshio Yamaoka; David Y Graham
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

6.  Identification of Helicobacter pylori in Saliva of Patients with and without Gastritis by Polymerase Chain Reaction.

Authors:  E V Soma Sekhar Goud; Ranganathan Kannan; Umadevi K Rao; Elizabeth Joshua; Rooban Tavaraja; Yash Jain
Journal:  J Pharm Bioallied Sci       Date:  2019-11

7.  Antioxidant and Antiulcerogenic Activity of the Dry Extract of Pods of Libidibia ferrea Mart. ex Tul. (Fabaceae).

Authors:  Lady D K T Prazeres; Ticiana P Aragão; Samara A Brito; Cynthia L F Almeida; Amanda D Silva; Mirella M F de Paula; Juliane S Farias; Leucio D Vieira; Bolívar P G L Damasceno; Larissa A Rolim; Bruno O Veras; Ismael G Rocha; Jacinto C Silva Neto; Milena L F Bittencourt; Rita de Cássia R Gonçalves; Rodrigo R Kitagawa; Almir G Wanderley
Journal:  Oxid Med Cell Longev       Date:  2019-11-20       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.